Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
D000208:Acute Disease; D000368:Aged; D001777:Blood Coagulation; D004359:Drug Therapy, Combination; D010450:Endopeptidases / Q000008:administration & dosage*; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008239:Lysine / Q000627:therapeutic use; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage* / Q000627:therapeutic use
D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator; D008239:Lysine